- Ayurcann Holdings (AYUR) has announced the approval of 15 additional product listings in Ontario, Alberta, Saskatchewan and Manitoba
- New products include CBN, high potency CBD oils and high potency Dablicators
- All products will be made available through adult-use stores, including authorized retailers across Canada
- Ayurcann is a post-harvest solution provider with a focus on custom processes and pharma-grade products for Canada’s adult-use and medical cannabis industry
- Ayurcann Holdings Corp. (AYUR) opened trading at C$0.06 per share
Ayurcann Holdings (AYUR) has announced the approval of 15 additional product listings in Ontario, Alberta, Saskatchewan and Manitoba.
Ayurcann will launch additional lines of products under its house brands ‘Fuego,’ ‘H&S,’ ‘XPLOR,’ ‘JOINTS’ and ‘BRAVO6’. New products include CBN, high potency CBD oils and high potency Dablicators.
With cannabis flower sales growth across the Canadian recreational market Ayurcann is pleased with the acceptance of 8 new product stock-keeping units. It will be offering high potency milled, pre-rolled and value flower. All products will be made available through adult-use stores, including authorized retailers across Canada.
Ayurcann will be launching the products across Canada, allowing for greater market penetration, including faster and more scaled distribution. Ayurcann has been executing its strategy to expand its market share in extract and extract derivatives while providing exceptional products and value to consumers.
Igal Sudman, Chief Executive Officer of Ayurcann, commented on the news.
“We are thrilled with the growth of Ayurcann and its products within the Canadian marketplace. With the ability to produce products that are embraced by cannabis consumers, offering value and innovation, we are optimistic about our future growth and the potential of becoming an industry leader. We have been successfully selling throughout various Provinces within Canada, including Ontario, British Columbia, Alberta, New Brunswick, Manitoba, and Saskatchewan, and believe that the continued interest from consumers and retailers will help elevate Ayurcann as a leader in the industry.”
Ayurcann is a post-harvest solution provider with a focus on custom processes and pharma-grade products for Canada’s adult-use and medical cannabis industries.
Ayurcann Holdings Corp. (AYUR) opened trading at C$0.06 per share.